Symbol="CRDF"
AssetType="Common Stock"
Name="Cardiff Oncology Inc"
Description="Cardiff Oncology, Inc., a clinical-stage biotechnology company, develops drugs for the treatment of cancer. The company is headquartered in San Diego, California."
CIK="1213037"
Exchange="NASDAQ"
Currency="USD"
Country="USA"
Sector="LIFE SCIENCES"
Industry="BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)"
Address="11055 FLINTKOTE AVENUE, SAN DIEGO, CA, US"
FiscalYearEnd="December"
LatestQuarter="2023-06-30"
MarketCapitalization="82758000"
EBITDA="-42290000"
PERatio="None"
PEGRatio="None"
BookValue="1.938"
DividendPerShare="0"
DividendYield="0"
EPS="-0.89"
RevenuePerShareTTM="0.009"
ProfitMargin="0"
OperatingMarginTTM="-103.51"
ReturnOnAssetsTTM="-0.233"
ReturnOnEquityTTM="-0.383"
RevenueTTM="412000"
GrossProfitTTM="-26721000"
DilutedEPSTTM="-0.89"
QuarterlyEarningsGrowthYOY="0"
QuarterlyRevenueGrowthYOY="0.187"
AnalystTargetPrice="7.33"
TrailingPE="-"
ForwardPE="-"
PriceToSalesRatioTTM="159.97"
PriceToBookRatio="0.564"
EVToRevenue="482.74"
EVToEBITDA="-9.38"
Beta="1.698"
num_52WeekHigh="3.31"
num_52WeekLow="1.2"
num_50DayMovingAverage="1.609"
num_200DayMovingAverage="1.6"
SharesOutstanding="44677200"
DividendDate="2019-02-20"
ExDividendDate="None"
symbol="CRDF"
open="1.92"
high="1.95"
low="1.81"
price="1.84"
volume="303625.00"
latest_trading_day="2023-08-18"
previous_close="1.92"
change="-0.08"
change_percent="-4.1667%"
aroon_positive_momentum_days="37"
aroon_negative_momentum_days="0"
trend_strength="Absent or Weak Trend"
buying_signal="Weak Buy Signal"
volume_analysis="Target Volume"
value_analysis="Expected Range"
Aroon_change="FALSE"
Aroon_momentum="37"
Volume_recent_avg="426408"
Change_recent_avg="-0.01"
Delta_recent_avg="0.12"
Variance_recent_avg="0.06"
Change_ratio_recent_avg="-0.5"
RSI_change="FALSE"
ADX_change="FALSE"

event="FALSE"
Aroon_signal="positive"
Aroon_change="FALSE"
Aroon_momentum_positive="37"
Aroon_momentum_negative="63"
image_negative_thumbnail_id_1="1123"
image_negative_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Negative_Landscape_0156.jpeg"
image_negative_thumbnail_id_2="1106"
image_negative_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Negative_Landscape_0139.jpeg"
image_neutral_thumbnail_id_1="544"
image_neutral_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0055.jpeg"
image_neutral_thumbnail_id_2="569"
image_neutral_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0030.jpeg"
image_positive_thumbnail_id_1="658"
image_positive_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0050.jpeg"
image_positive_thumbnail_id_2="606"
image_positive_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0102.jpeg"
image_professor_thumbnail_id_1="1198"
image_professor_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0032.jpeg"
image_professor_thumbnail_id_2="1178"
image_professor_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0012.jpeg"
